Records are supplied by study sponsors and investigators. A registry listing is not an endorsement or a guarantee of safety, availability or eligibility.
WCR feed checked: Nov 12, 2026.
By invitationNCT06940752
Ventricular Arrhythmia
Not applicable21 years - 100 yearsAtlanta, Georgia, United States Background: Ventricular arrhythmia is an abnormal pulse rhythm that starts in the lower part of the heart (ventricles). Treatment includes ablation; ablation uses heat to destroy small portions of the heart that are causing short circuits in the norm…
Not yet recruitingNCT07928336
Ischemic Heart Disease (IHD)
Observational18 years - Not specifiedSohag, Egypt This study aims to investigate the association between insulin resistance (IR) and coronary artery disease (CAD) in non-diabetic patients. Furthermore, it evaluates the predictive value of multiple insulin resistance indices - specifically, the homeo…
CompletedNCT01020838
Alzheimer Disease
Phase 321 years - Not specifiedSun City, Arizona, United States +16 To determine the sensitivity and specificity of the visual assessment of tracer uptake in the Florbetaben PET images compared to histological verification of the presence or absence of cerebral β-amyloid in the respective histopathologic post mortem …
Not yet recruitingNCT07929844
Onychomycosis of Toenails
Phase 218 years - 70 yearsLos Angeles, California, United States +4 This is a parallel group, double blind, vehicle-controlled study in which SKX-16 or vehicle (2:1 randomization) is applied once a day for 52 weeks to all affected toenails to participants with mild to moderate distal subungual onychomycosis (DSO) of …
RecruitingNCT06079671
Locally Advanced Cervical Cancer
Phase 315 years - Not specifiedBirmingham, Alabama, United States +160 This is a phase III, randomized, double-blind, placebo-controlled, multi-center, global study to explore the efficacy and safety of volrustomig in women with high-risk LACC (FIGO 2018 stage IIIA to IVA cervical cancer) who have not progressed followi…
RecruitingNCT05685628
Malodorous Wounds (Chronic, Malignant or Infected Wounds)
Not applicable18 years - Not specifiedCréteil, France +3 Refer to "Detailed description".
Not yet recruitingNCT07718529
Ulcerative Colitis in Remission
Phase 418 years - Not specifiedAmiens, France +18 This phase IV, multicenter, open-label randomized controlled trial will evaluate whether a JAK inhibitor discontinuation strategy is superior to standard maintenance therapy in adult patients with ulcerative colitis who are in sustained deep remissio…
RecruitingNCT05712577
Rare Diseases · Marfan Syndrome · Psychology, Social
Observational18 years - Not specifiedSan Donato Milanese, Lombardy, Italy The goal of this observational study is to identify key factors leading to psychotherapy or psychological support in adult subjects with Marfan syndrome (MSF). the main questions it aims to answer are: * Understand and define which internal variables…
RecruitingNCT03589729
Acute Myeloid Leukemia · Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive · Blasts 10 Percent or More of Bone Marrow Nucleated Cells · High Risk Myelodysplastic Syndrome · Myeloid Sarcoma · Myeloproliferative Neoplasm · Philadelphia Chromosome Positive
Phase 212 years - Not specifiedHouston, Texas, United States This phase II trial studies how well dexrazoxane hydrochloride works in preventing heart-related side effects of chemotherapy in participants with blood cancers, such as acute myeloid leukemia, myelodysplastic syndrome, chronic myeloid leukemia, and …
CompletedNCT07490171
Trauma
Observational18 years - Not specifiedDallas, Texas, United States This retrospective data repository will serve as a means to aggregate and analyze order of pre-hospital care (intubation, medication, etc) as it relates to Traumatic cardiac arrest.
RecruitingNCT03258567
Epstein-Barr Virus Infections · Lymphoma · Lymphoproliferative Disorder · Disorders, Lymphoproliferative
Phase 212 years - Not specifiedBethesda, Maryland, United States Background: The drug Nivolumab has been approved to treat some cancers. Researchers want to see if it can slow the growth of other cancers. They want to study its effects on cancers that may have not responded to chemotherapy or other treatments. Obj…
Active, not recruitingNCT07534592
Healthy Participants
Phase 118 years - 55 yearsGlendale, California, United States +1 The study has 2 groups, one each focusing on co-administration of elecoglipron and atorvastatin or rosuvastatin to assess the pharmacokinetics (PK) of atorvastatin in healthy participants.
Retrieved from ClinicalTrials.gov: Nov 12, 2026. Overall study status may differ from a particular location’s status.
